Previous 10 | Next 10 |
2023-11-20 07:30:00 ET The kind of stock whose value can double overnight is often also the kind that can become almost worthless about as quickly. So, investors shouldn't chase out such gains in a short period. However, solid, well-established corporations can safely see their share prices...
2023-11-17 14:00:04 ET More on Exact Sciences Exact Sciences Corporation 2023 Q3 - Results - Earnings Call Presentation Exact Sciences Looks Fairly Valued After Its Q3 Earnings Beat Exact Sciences Corporation (EXAS) Q3 2023 Earnings Call Transcript Exact Scie...
Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy PR Newswire Company asserts that Geneoscopy infringed patented technology central to its Cologuard colorectal cancer screening test MADISON, Wis. , Nov. 17, 2023 /PRNewswire/ -- Exact Science...
2023-11-14 05:20:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Multi-billionaire investor Ken Fisher wrote recently that the stocks of relatively small companies tend to be very unpopular with the Street during the early phase of bull markets. Therefor...
2023-11-02 00:30:42 ET Image source: The Motley Fool. Exact Sciences (NASDAQ: EXAS) Q3 2023 Earnings Call Nov 01, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
2023-11-01 21:44:52 ET Summary Exact Sciences Corporation focuses on early cancer detection and prevention through products like Cologuard, Oncotype DX, and Oncotype MAP. Despite the Q3 2023 earnings beat, the company's lack of substantial earnings cast valuation doubts at a marke...
2023-11-01 20:28:08 ET Exact Sciences Corporation (EXAS) Q3 2023 Earnings Conference Call November 1, 2023 05:00 p.m. ET Company Participants Kevin Conroy - Chairman, Chief Executive Officer Jeff Elliott - Chief Financial Officer Everett Cunningham - Chief Commer...
2023-11-01 16:10:55 ET More on Exact Sciences Exact Sciences: Adjusting My Strategy After Encouraging Q2 Earnings Exact Sciences Q3 2023 Earnings Preview Exact Sciences upgraded at Piper Sandler on compelling entry point Seeking Alpha’s Quant Rating on...
Exact Sciences Announces Third-Quarter 2023 Results PR Newswire Reports record revenue, delivers more than a million test results, raises full-year guidance Third -quarter 2023 highlights Total third quarter revenue of $628 million , an increase of 20%, or ...
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
News, Short Squeeze, Breakout and More Instantly...
Exact Sciences Corporation Company Name:
EXAS Stock Symbol:
NASDAQ Market:
Exact Sciences Corporation Website:
2024-07-11 08:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 08:30:00 ET To say that Exact Sciences (NASDAQ: EXAS) hasn't performed well on the stock market this year would be an understatement. Shares of the cancer-focused biotech are down by 41%. However, the healthcare company still has some fans on Wall Street. Cathie Wood ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2024 financial results after the close of the U.S. financial markets on July 31, 2024. Following the release, company management w...